Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update

R Vanholder, A Pletinck, E Schepers, G Glorieux - Toxins, 2018 - mdpi.com
In this narrative review, the biological/biochemical impact (toxicity) of a large array of known
individual uremic retention solutes and groups of solutes is summarized. We classified these …

Production of indole and indole-related compounds by the intestinal microbiota and consequences for the host: the good, the bad, and the ugly

N Tennoune, M Andriamihaja, F Blachier - Microorganisms, 2022 - mdpi.com
The intestinal microbiota metabolic activity towards the available substrates generates
myriad bacterial metabolites that may accumulate in the luminal fluid. Among them, indole …

Indoxyl sulfate, a uremic endotheliotoxin

G Lano, S Burtey, M Sallée - Toxins, 2020 - mdpi.com
Chronic kidney disease (CKD) is associated with a high prevalence of cardiovascular
diseases. During CKD, the uremic toxin indoxyl sulfate (IS)—derived from tryptophan …

Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease

JD Ravid, MH Kamel, VC Chitalia - Nature Reviews Nephrology, 2021 - nature.com
Chronic kidney disease (CKD) is characterized by the retention of a myriad of solutes termed
uraemic (or uremic) toxins, which inflict damage to several organs, including the …

Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality

I Nemet, XS Li, A Haghikia, L Li, J Wilcox… - European Heart …, 2023 - academic.oup.com
Aims Precision microbiome modulation as a novel treatment strategy is a rapidly evolving
and sought goal. The aim of this study is to determine relationships among systemic gut …

Chronic kidney disease in the pathogenesis of acute ischemic stroke

B Chelluboina, R Vemuganti - Journal of Cerebral Blood …, 2019 - journals.sagepub.com
Chronic kidney disease has a graded and independent inverse impact on cerebrovascular
health. Both thrombotic and hemorrhagic complications are highly prevalent in chronic …

Tryptophan-derived uremic toxins and thrombosis in chronic kidney disease

T Addi, L Dou, S Burtey - Toxins, 2018 - mdpi.com
Patients with chronic kidney disease (CKD) display an elevated risk of thrombosis.
Thrombosis occurs in cardiovascular events, such as venous thromboembolism, stroke, and …

Platelet function in CKD: a systematic review and meta-analysis

CC Baaten, M Sternkopf, T Henning… - Journal of the …, 2021 - journals.lww.com
Background Patients with CKD are at high risk for thrombotic and hemorrhagic
complications. Abnormalities in platelet function are central to these complications, but …

Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model

M Karbowska, JM Hermanowicz… - Scientific reports, 2020 - nature.com
Chronic kidney disease (CKD) is deemed to be a worldwide health concern connected with
neurological manifestations. The etiology of central nervous system (CNS) disorders in CKD …

Platelets in renal disease

D Gomchok, RL Ge, T Wuren - International Journal of Molecular …, 2023 - mdpi.com
Kidney disease is a major global health concern, affecting millions of people. Nephrologists
have shown interest in platelets because of coagulation disorders caused by renal diseases …